Delivery Order 36C26125D0024-36C26126N0371
- Not listed
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, has been awarded a firm fixed-price delivery order valued at $432,681.74 by Veterans Integrated Service Network 5 (VISN 5) for the supply of radiopharmaceutical products. The award, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, carries no set-aside designation and represents performance at the contractor's Lake Mary, Florida facility. This delivery order is issued under an...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, has been awarded a $322,968.95 firm fixed-price delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 22 for the supply of radiopharmaceutical products. The award, issued on December 12, 2025, with a completion date of December 11, 2026, does not include a set-aside designation and represents a call against an existing Indefinite Delivery Vehicle. Performance will take...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, received a delivery order award from the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 on January 1, 2026, for the supply of radiopharmaceuticals for nuclear medicine patients. The contract carries a firm fixed-price ceiling value of $493,958.37 with an ultimate completion date of December 31, 2026, and will be performed in Lake Mary, Florida. This delivery order is not designated as a set-aside contract and...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a firm fixed-price purchase order valued at $882,014.09 by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 20 on March 1, 2020. The contract, which is set aside for 8(a) small businesses under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), calls for the supply of radiopharmaceuticals to support nuclear medicine diagnostic and therapeutic...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, has been awarded a $505,759.50 firm fixed-price purchase order by the Department of Veterans Affairs' Veterans Integrated Service Network 12 for the supply of nuclear medicine radiopharmaceuticals. The award, effective January 1, 2026, through December 31, 2026, supports the Edward J. Hines, Jr. VA Hospital in Hines, Illinois, and addresses the facility's Nuclear Medicine Clinic requirements for unit...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 17 awarded a $990,211 delivery order for radiopharmaceuticals to RLS (USA) Inc., a foreign-owned radiopharmacy company specializing in nuclear medicine products for federal healthcare agencies. The contract employs firm fixed pricing and is not designated as a set-aside. RLS (USA) Inc. will perform work at its facility in Lake Mary, Florida, with an ultimate completion date of September 17, 2026. This delivery order...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a delivery order to RLS (USA) Inc. for radiopharmaceutical base supply services with a ceiling value of $1.56 million, effective April 1, 2026 through March 31, 2027. This firm fixed-price delivery order was issued without set-aside designation and calls for performance at RLS's facility in Lake Mary, Florida. RLS (USA) Inc. is a foreign-owned radiopharmacy company specializing in the supply of...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, was awarded a firm fixed-price purchase order valued at $1,747,515.93 by the Department of Veterans Affairs, Veterans Integrated Service Network 12 (VISN 12), on March 1, 2026, for the supply of radiopharmaceuticals and nuclear medicine products. This unrestricted acquisition, with no set-aside designation, will support diagnostic imaging procedures at the Clement J. Zablocki VA Medical Center in...
- RLS (USA) Inc., a foreign-owned radiopharmacy company headquartered in Lake Mary, Florida, received a $431,476 firm fixed-price delivery order from the Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21) for cyclotron radiopharmaceuticals with a performance period from April 1, 2026 through March 31, 2027. This delivery order was awarded without a set-aside designation and represents a call against one of RLS (USA) Inc.'s existing Indefinite Delivery Vehicles with...
- RLS (USA) Inc., a foreign-owned radiopharmacy company, has been awarded a delivery order valued at $91,658.40 by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) for the supply of NETSPOT GA-68 (Gallium-68 Dotatate), a radiopharmaceutical used in nuclear medicine diagnostic imaging. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 31, 2026, and will be performed at the contractor's facility in...
- 36C26125D0024Indefinite Delivery Contract
- 36C26125D0024-36C26126N0371Delivery Order
RLS (USA) Inc., a radiopharmacy company headquartered in Lake Mary, Florida, was awarded a delivery order valued at $250,075.29 by the Department of Veterans Affairs' Northern California Health Care System (Veterans Integrated Service Network 21) for radiopharmaceuticals and radiopharmaceutical supplies. The contract, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, utilizes firm fixed-price pricing and is not designated as a set-aside contract. This delivery order falls under a larger $2.5 million indefinite delivery vehicle that RLS (USA) Inc. maintains with VA VISN 21 for radiopharmaceutical procurement, enabling the healthcare system to obtain time-sensitive nuclear medicine diagnostic imaging agents and related supplies on an as-needed basis. RLS (USA) Inc. operates 31 radiopharmacy facilities across 18 states and serves as a critical supplier of specialized medical isotopes to the VA and Defense Health Agency, offering a comprehensive portfolio that includes technetium-99m compounds, fluorodeoxyglucose F-18, gallium-67, iodine isotopes, indium-111, and specialty products such as Cardiolite and NETSPOT. The company has established itself as a preferred federal supplier through an extensive portfolio of indefinite delivery vehicles, including major contracts exceeding $4.9 million with VA VISN 17 and $3 million with VA VISN 20, demonstrating the federal government's confidence in RLS (USA) Inc.'s capacity to reliably deliver the specialized, time-sensitive radiopharmaceuticals essential for diagnostic and therapeutic nuclear medicine procedures across the VA healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $250.1k | 3/16/26 |